Print

Print


------ =_NextPart_000_01BD639D.521BA280
Content-Type: text/plain; charset="us-ascii"
Content-Transfer-Encoding: quoted-printable

Eddie,

I'm not a doctor but it would seem extremely premature to cut back the =
Sinemet while just starting to titrate up on the Tasmar.  I believe the =
norm is to wait until feel dykenesias or some other over-medicated =
symptom before you start to reduce the Sinemet.

In my humble opinion

Good luck
Bill

-----Original Message-----
From:   Edward W Raasch Jr [SMTP:[log in to unmask]]
Sent:   Thursday, April 09, 1998 8:36 AM
To:     Multiple recipients of list PARKINSN
Subject:        Tasmar

  Hi All

       Mom started Tasmar yesterday and is in a major struggle just to
  move.  He doctor cut the simemet in half, from 6 25/100's down to =
three.
  Can anyone share their Tasmar advice/experience with me?

  Eddie
  CG for mom  77/12

------ =_NextPart_000_01BD639D.521BA280
Content-Type: application/ms-tnef
Content-Transfer-Encoding: base64
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------ =_NextPart_000_01BD639D.521BA280--